Symphony Technology Group Acquires Kantar Reputation Intelligence, PRgloo and Onclusive to Create a New Global Partner for PR and Communications
Today, leading technology investor Symphony Technology Group “STG” completes its acquisition of Kantar’s Reputation Intelligence business, and with it announces the additional purchases of PRgloo and Onclusive. Together the three businesses merge to create a new global media monitoring, measurement, and workflow management partner for PR and communications.
The new standalone company will operate under the name ‘Onclusive’ reflecting the inclusive and scalable nature of its newly combined offer and its commitment to accelerating investment in tech-powered platforms and solutions.
The company builds on the consultative strengths and scale of Europe’s largest media monitoring and analysis provider, Kantar Reputation Intelligence; UK-based PRgloo’s industry-leading media relations and workflow management platform and US-based Onclusive’s AI technology and data science.
Commenting on the new company, Chief Commercial Officer of the newly-formed Onclusive, Petra Masinova explained: “We’ve always admired each other’s strengths and we’ve increasingly teamed up on programmes to help solve clients’ needs. Today we accelerate our natural evolution to become one company, amplifying our strengths and supporting our clients with leading insights, technology and expertise together under one roof.”
Dan Beltramo, Chief Innovation Officer of the new Onclusive, also praised the union: “Onclusive is a technology and innovation pioneer in media monitoring and analytics while Kantar Reputation Intelligence is a leader in customer service with top-tier European coverage and market-leading insights capabilities. It brings us scale and ambition for global leadership.”
Samantha Deeks, VP Customer Experience at new Onclusive added: “Building on PRgloo’s customer-centric design approach, we’re delighted to work with like-minded industry leaders to build a scalable and agile business; one which actively listens and responds to the needs of its clients as they navigate an increasingly complex communications environment.”
Managing Director at STG, J.T. Treadwell, said: “Last year STG made clear its intention to create a market leading insights and software company through the proposed acquisition of Kantar Reputation Intelligence. Completing that acquisition is a major first step and the additional capabilities brought by Onclusive and PRgloo widen the scope of our commitment to providing best-in-class solutions for PR and Communications teams, both now and in the future.”
Onclusive will serve more than 9,000 clients, including many of the world’s biggest brands, across 130 markets. The company has over 1,100 employees based in the USA, UK, Ireland, France, Italy, Spain, Germany and Australia.
Onclusive North America Managing Director, Sean O’Neal, continued: “Our clients were our matchmakers – they told us they wanted one trusted partner to help them access and integrate our combined best-in-class services. We listened and from today Onclusive will help every client – from small enterprises to multi-national public and private organisations – shape, manage and evaluate their communications strategies.”
From today, clients can access the new Onclusive’s full range of services, supporting them at every stage of the communications cycle. Existing services continue uninterrupted.
About Onclusive
Onclusive is a global partner for PR and Communications success. We bring together Kantar Reputation Intelligence, the largest media monitoring and measurement service in Europe, with the best-in-class tools of PRgloo, and Onclusive’s own powerful AI and data science. Our technology, insights and expertise make sense of the fractured, fast-moving media world, helping you manage, monitor and measure your communications activity. Elevate your performance and prove and improve your value with Onclusive on your side.
About STG Partners
STG is a private equity partner to market leading companies in software, data analytics and software-enabled technology services sectors. The firm brings expertise, flexibility, and resources to build strategic value and unlock the potential of innovative companies. Partnering to build customer-centric, market leading portfolio companies, STG seeks to create sustainable foundations for growth that bring value to its companies. The firm is dedicated to transforming and building outstanding technology companies in partnership with leading management teams. STG and its predecessor, Symphony Technology Group (“Symphony”), have managed approximately $6 billion in total capital. For more information, please visit stgpartners.com
Kantar Reputation Intelligence – The leader in earned media tracking and measurement in Europe. Reputation Intelligence provides trusted insights on corporate, PR and brand coverage in 130+ markets to brands can understand and manage how audiences and influencers see them, globally and locally.
Onclusive – Empowers the world’s leading brands and agencies to modernize communications, increase performance and demonstrate value. The inventors of PR Attribution™ and Power of Voice™, Onclusive measures the true impact of earned, owned and social content on a company’s bottom line.
PRgloo – The complete media relations platform. PRgloo combines easy to use tools with exceptional analysis to make PR professionals’ lives easier by giving them the tools they need to do their jobs well.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220104005044/en/
Contact information
For further information contact
Corey Herscu for Onclusive (North America)
416-300-3030
corey@verbfactory.com
onclusiveteam@firstlightgroup.io
+44 020 36177240
Learn more at: future.onclusive.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA ™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 14:00:00 EEST | Press release
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the durable benefit that vimseltinib can offer patients.” Summary of Data and Findings from the 2-year results of the MOTION Phase
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 17:09:00 EEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 17:00:00 EEST | Press release
Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the study increased considerably to 76.2% (95% CI: 63.8, 86.0) by blinded independent review committee (BICR) per RECIST v1.1, from 54% at Week 25. The study also showed continued clinically meaningful improvements in key secondary endpoints related to patient outcomes such as pain and function. The safety profile was consistent with previously reported data. The results are being presented today in the Sarcoma mini-oral session at the European Society for Medical
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 16:04:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B cell-mediated diseases. Pove is the only BAFF+APRIL inhibitor in pivotal trials for multiple kidney diseases. Next Steps for Pove Development In IgAN Following the announcement that the Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) to pove for the treatment of IgAN, FDA recently granted a rolling review of the Biologics License Application (BLA) for pove for this indication. Vertex expects to submit the first module to FDA for potential accelerated approval before t
Qualcomm Announces Quarterly Cash Dividend17.10.2025 16:00:00 EEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom